Invention Grant
- Patent Title: Ketoreductase polypeptides
-
Application No.: US16031177Application Date: 2018-07-10
-
Publication No.: US10246687B2Publication Date: 2019-04-02
- Inventor: Emily Mundorff , Erik Jan De Vries
- Applicant: Codexis, Inc.
- Applicant Address: US CA Redwood City
- Assignee: Codexis, Inc.
- Current Assignee: Codexis, Inc.
- Current Assignee Address: US CA Redwood City
- Agency: Codexis, Inc.
- Main IPC: C12N9/02
- IPC: C12N9/02 ; C12N9/04 ; C07H21/04 ; C12P17/10 ; C12P7/02 ; C12P41/00 ; C12P17/14 ; C12N15/00 ; C12N15/75

Abstract:
The present disclosure provides engineered ketoreductase enzymes having improved properties as compared to a naturally occurring wild-type ketoreductase enzyme including the capability of reducing 5-((4S)-2-oxo-4-phenyl (1,3-oxazolidin-3-yl))-1-(4-fluorophenyl) pentane-1,5-dione to (4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one. Also provided are polynucleotides encoding the engineered ketoreductase enzymes, host cells capable of expressing the engineered ketoreductase enzymes, and methods of using the engineered ketoreductase enzymes to synthesize the intermediate (4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one in a process for making Ezetimibe.
Public/Granted literature
- US20180312817A1 KETOREDUCTASE POLYPEPTIDES Public/Granted day:2018-11-01
Information query